XML 21 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
OPERATING ACTIVITIES:    
Net income (loss) $ 569 $ (13)
Adjustments to reconcile to net cash provided (used) by operating activities:    
Depreciation and amortization 442 445
Provision (benefit) for deferred income taxes 28 2
Net (gain) loss on disposition of equity-method investments (269) 0
Impairment of equity-method investments 0 112
Amortization of stock-based awards 21 21
Cash provided (used) by changes in current assets and liabilities:    
Accounts and notes receivable 29 298
Inventories (30) (16)
Other current assets and deferred charges 18 16
Accounts payable 32 (23)
Accrued liabilities (133) (141)
Other, including changes in noncurrent assets and liabilities (101) 82
Net cash provided (used) by operating activities 606 783
FINANCING ACTIVITIES:    
Proceeds from (payments of) commercial paper – net (93) (365)
Proceeds from long-term debt 470 2,688
Payments of long-term debt (2,000) (1,991)
Proceeds from issuance of common stock 2,122 6
Dividends paid (248) (480)
Dividends and distributions paid to noncontrolling interests (242) (236)
Contributions from noncontrolling interests 4 16
Payments for debt issuance costs 0 (8)
Other – net (28) (3)
Net cash provided (used) by financing activities (15) (373)
INVESTING ACTIVITIES:    
Capital expenditures (1) (511) (513)
Net proceeds from dispositions (2) 24
Proceeds from dispositions of equity-method investments 200 0
Purchases of and contributions to equity-method investments (52) (63)
Distributions from unconsolidated affiliates in excess of cumulative earnings 121 109
Other – net 122 97
Net cash provided (used) by investing activities (122) (346)
Increase (decrease) in cash and cash equivalents 469 64
Cash and cash equivalents at beginning of year 170 100
Cash and cash equivalents at end of period 639 164
(1) Increases to property, plant, and equipment (569) (525)
Changes in related accounts payable and accrued liabilities 58 12
Capital expenditures (1) $ (511) $ (513)